Soft tissue sarcoma, version 2.2018: Clinical practice guidelines in oncology

Academic Article

Abstract

  • © JNCCN-Journal of the National Comprehensive Cancer Network. Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for STS provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intraabdominal/retroperitoneal STS, gastrointestinal stromal tumors, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis, staging, and treatment of STS of the extremities, superficial trunk, or head and neck; outlines treatment recommendations by disease stage; and reviews the evidence to support the guidelines recommendations.
  • Digital Object Identifier (doi)

    Author List

  • Mehren MV; Randall RL; Benjamin RS; Boles S; Bui MM; Ganjoo KN; George S; Gonzalez RJ; Heslin MJ; Kane JM
  • Start Page

  • 536
  • End Page

  • 563
  • Volume

  • 16
  • Issue

  • 5